Search Results - "Segami, María I."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Strongyloides Stercoralis Hyperinfection in Systemic Lupus Erythematosus and the Antiphospholipid Syndrome by Mora, Claudia S., Segami, María I., Hidalgo, José A.

    Published in Seminars in arthritis and rheumatism (01-12-2006)
    “…The Strongyloides stercoralis hyperinfection syndrome (SHS) may develop in individuals with asymptomatic infection receiving immunosuppressive treatment. This…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Infliximab en pacientes con espondilitis anquilosante activa: experiencia en el Hospital Nacional Edgardo Rebagliati Martins by Montero, Manuel, García-Poma, Augusto, Chung, Cecilia, Chávez, JosÃ, Segami, María I

    “…Infliximab es un medicamento efectivo en el tratamiento de pacientes con espondilitis anquilosante (EA) activa. Sin embargo, debido a su alto costo, su uso…”
    Get full text
    Journal Article
  8. 8

    Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis by García-Poma, Augusto, Segami, Maria I, Mora, Claudia S, Ugarte, Manuel F, Terrazas, Henry N, Rhor, Eduardo A, García, Elmer, Ramos, María P, Alva, Magaly, Castañeda, Isabel, Chung, Cecilia P

    Published in Clinical rheumatology (01-11-2007)
    “…Obesity is a modifiable major cause of morbidity and mortality in the general population, but little is known about the association of obesity and quality of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Pamidronato endovenoso en espondilitis anquilosante refractaria a antiinflamatorios no esteroideos y sulfasalazina by García-Poma, Augusto, Montero-Jauregui, Manuel, Terrazas, Henry, Miraval, Tatiana, Becerra, Felipe, Segami, María I

    “…Objetivo: Evaluar la terapia con pamidronato, en pacientes con espondilitis anquilosante (EA) activa, con respuesta subóptima o falla a los antiinflamatorios…”
    Get full text
    Journal Article
  12. 12

    The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients by CHUNG, Cecilia P, RUSSELL, Anthony S, SEGAMI, Maria I, UGARTE, César A

    Published in Rheumatology international (01-03-2005)
    “…The aim of this study was to determine the difference between bone mineral density (BMD) of rheumatoid arthritis (RA) patients on low-dose prednisone and…”
    Get full text
    Journal Article
  13. 13

    Pamidronato endovenoso en espondilitis anquilosante refractaria a antiinflamatorios no esteroideos (AINES) y sulfasalazina by García-Poma, Augusto, Montero-Jauregui, Manuel, Terrazas, Henry, Miraval, Tatiana, Becerra, Felipe, Segami, María I

    “…Objetivo: Evaluar la terapia con pamidronato, en pacientes con espondilitis anquilosante (EA) activa, con respuesta subóptima o falla a los antiinflamatorios…”
    Get full text
    Journal Article
  14. 14

    Infliximab en pacientes con espondilitis anquilosante activa: experiencia en el Hospital Nacional Edgardo Rebagliati Martins by Montero, Manuel, García-Poma, Augusto, Chung, Cecilia, Chávez, José, Segami, María I.

    “…Infliximab es un medicamento efectivo en el tratamiento de pacientes con espondilitis anquilosante (EA) activa. Sin embargo, debido a su alto costo, su uso…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19